Statin prescribing among hypertensive patients in south-west Nigeria: findings and implications for the future

Onyinye Onyeka Akunne, Brian Godman, Aduragbenro Deborah Adedapo, Ilse Truter, Joseph Fadare

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Statins reduce cardiovascular risk especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Our aim is to ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generics. Prospective study involving hypertensive patients attending University College Hospital, Ibadan, Nigeria. 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generics was US$2,635 for atorvastatin and US$10578 for rosuvastatin. A shift towards increased prescribing generics is recommended to minimize costs
LanguageEnglish
Pages281-288
Number of pages8
JournalJournal of Comparative Effectiveness Research
Volume5
Issue number3
DOIs
Publication statusPublished - 31 May 2016

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nigeria
fluvastatin
Costs and Cost Analysis
Simvastatin
Prospective Studies
Blood Pressure
Hypertension

Keywords

  • statins
  • hypertension
  • Nigeria
  • generics
  • costs

Cite this

Akunne, Onyinye Onyeka ; Godman, Brian ; Adedapo, Aduragbenro Deborah ; Truter, Ilse ; Fadare, Joseph. / Statin prescribing among hypertensive patients in south-west Nigeria : findings and implications for the future . In: Journal of Comparative Effectiveness Research. 2016 ; Vol. 5, No. 3. pp. 281-288.
@article{800d1a906756433bb29acc0ac5ce36c2,
title = "Statin prescribing among hypertensive patients in south-west Nigeria: findings and implications for the future",
abstract = "Statins reduce cardiovascular risk especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Our aim is to ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generics. Prospective study involving hypertensive patients attending University College Hospital, Ibadan, Nigeria. 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generics was US$2,635 for atorvastatin and US$10578 for rosuvastatin. A shift towards increased prescribing generics is recommended to minimize costs",
keywords = "statins, hypertension, Nigeria, generics, costs",
author = "Akunne, {Onyinye Onyeka} and Brian Godman and Adedapo, {Aduragbenro Deborah} and Ilse Truter and Joseph Fadare",
year = "2016",
month = "5",
day = "31",
doi = "10.2217/CER.15.65",
language = "English",
volume = "5",
pages = "281--288",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6313",
number = "3",

}

Statin prescribing among hypertensive patients in south-west Nigeria : findings and implications for the future . / Akunne, Onyinye Onyeka; Godman, Brian; Adedapo, Aduragbenro Deborah; Truter, Ilse; Fadare, Joseph.

In: Journal of Comparative Effectiveness Research, Vol. 5, No. 3, 31.05.2016, p. 281-288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Statin prescribing among hypertensive patients in south-west Nigeria

T2 - Journal of Comparative Effectiveness Research

AU - Akunne, Onyinye Onyeka

AU - Godman, Brian

AU - Adedapo, Aduragbenro Deborah

AU - Truter, Ilse

AU - Fadare, Joseph

PY - 2016/5/31

Y1 - 2016/5/31

N2 - Statins reduce cardiovascular risk especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Our aim is to ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generics. Prospective study involving hypertensive patients attending University College Hospital, Ibadan, Nigeria. 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generics was US$2,635 for atorvastatin and US$10578 for rosuvastatin. A shift towards increased prescribing generics is recommended to minimize costs

AB - Statins reduce cardiovascular risk especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Our aim is to ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generics. Prospective study involving hypertensive patients attending University College Hospital, Ibadan, Nigeria. 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generics was US$2,635 for atorvastatin and US$10578 for rosuvastatin. A shift towards increased prescribing generics is recommended to minimize costs

KW - statins

KW - hypertension

KW - Nigeria

KW - generics

KW - costs

U2 - 10.2217/CER.15.65

DO - 10.2217/CER.15.65

M3 - Article

VL - 5

SP - 281

EP - 288

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6313

IS - 3

ER -